erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Rickettsia Infections D012282 5 associated lipids
Rickettsiaceae Infections D012288 2 associated lipids
Rosacea D012393 13 associated lipids
Rubella D012409 2 associated lipids
Salpingitis D012488 2 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Scarlet Fever D012541 1 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Sebaceous Gland Diseases D012625 1 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Seizures D012640 87 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Sialadenitis D012793 1 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Sinusitis D012852 9 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Skin Neoplasms D012878 12 associated lipids
Skin Ulcer D012883 6 associated lipids
Splenic Infarction D013159 1 associated lipids
Splenomegaly D013163 4 associated lipids
Sporotrichosis D013174 3 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Staphylococcal Scalded Skin Syndrome D013206 1 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Stomach Diseases D013272 7 associated lipids
Stomatitis D013280 14 associated lipids
Streptococcal Infections D013290 4 associated lipids
Surgical Wound Dehiscence D013529 3 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Synovitis D013585 15 associated lipids
Syphilis D013587 6 associated lipids
Syphilis, Cardiovascular D013589 1 associated lipids
Syphilis, Congenital D013590 3 associated lipids
Syphilis, Cutaneous D013591 1 associated lipids
Syphilis, Latent D013592 4 associated lipids
Tachycardia D013610 7 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Thromboembolism D013923 6 associated lipids
Thyroid Crisis D013958 1 associated lipids
Onychomycosis D014009 2 associated lipids
Tooth Diseases D014076 2 associated lipids
Tooth Fractures D014082 2 associated lipids
Tooth, Impacted D014095 9 associated lipids
Toothache D014098 3 associated lipids
Toxoplasmosis, Animal D014124 5 associated lipids
Tremor D014202 15 associated lipids
Trench Fever D014205 1 associated lipids
Trisomy D014314 6 associated lipids
Tuberculosis D014376 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Typhus, Epidemic Louse-Borne D014438 1 associated lipids
Uremia D014511 33 associated lipids
Urethral Diseases D014522 4 associated lipids
Urethritis D014526 9 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Urticaria D014581 13 associated lipids
Uveitis D014605 14 associated lipids
Varicose Ulcer D014647 4 associated lipids
Vibrio Infections D014735 5 associated lipids
Vomiting D014839 21 associated lipids
Vulvovaginitis D014848 2 associated lipids
Whooping Cough D014917 6 associated lipids
Wound Infection D014946 12 associated lipids
Wounds, Gunshot D014948 2 associated lipids
Xerostomia D014987 6 associated lipids
Yaws D015001 4 associated lipids
Superinfection D015163 3 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Scleritis D015423 3 associated lipids
Weight Gain D015430 101 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Granuloma, Respiratory Tract D015769 1 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Eye Infections, Parasitic D015822 2 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Torsades de Pointes D016171 2 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Bacteremia D016470 9 associated lipids
Foot Ulcer D016523 4 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Critical Illness D016638 13 associated lipids
Empyema, Pleural D016724 2 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ehrlichiosis D016873 2 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Chalazion D017043 1 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Skin Diseases, Viral D017193 2 associated lipids
Gastric Outlet Obstruction D017219 1 associated lipids
Skin Diseases, Papulosquamous D017444 2 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Sorensen EM and Acosta D Erythromycin estolate-induced toxicity in cultured rat hepatocytes. 1985 Toxicol. Lett. pmid:4060187
Saxena RP et al. Coir fibre toxicity: in vivo and in vitro studies. 1982 Toxicol. Lett. pmid:6283694
Mazur CS et al. P-glycoprotein inhibition by the agricultural pesticide propiconazole and its hydroxylated metabolites: Implications for pesticide-drug interactions. 2015 Toxicol. Lett. pmid:25268938
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Mahgoub A et al. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. 2005 Toxicol. Appl. Pharmacol. pmid:15885263
Gracia T et al. Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds. 2007 Toxicol. Appl. Pharmacol. pmid:17822730
Gant TW et al. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. 1995 Toxicol. Appl. Pharmacol. pmid:7645023
Fujii E et al. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study. 2008 Toxicol. Appl. Pharmacol. pmid:18355581
Dakhel Y and Jamali F Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. 2006 Toxicol. Appl. Pharmacol. pmid:16466760
Gray JE et al. Drug-induced enteropathy characterized by lipid in macrophages. 1974 Toxicol. Appl. Pharmacol. pmid:4136643
Gray JE et al. Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals. 1971 Toxicol. Appl. Pharmacol. pmid:4328315
Iwamoto HK and Brennan WR The effect of demeclocycline, methacycline, and erythromycin on tooth color in the rat. 1969 Toxicol. Appl. Pharmacol. pmid:4975609
Dujovne CA Liver cell culture toxicity and surfactant potency of erythromycin derivatives. 1975 Toxicol. Appl. Pharmacol. pmid:1135866
Sadrieh N and Thomas PE Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. 1994 Toxicol. Appl. Pharmacol. pmid:8048065
WORTH HM et al. INTRAGASTRIC INJECTION FOR TOXICITY STUDIES WITH NEWBORN RATS. 1963 Toxicol. Appl. Pharmacol. pmid:14082477
Gray JE et al. Foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin. 1978 Toxicol. Appl. Pharmacol. pmid:725925
Kalsotra A et al. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. 2004 Toxicol. Appl. Pharmacol. pmid:15364545
DeSalva SJ et al. Lethal effects of antibiotics in hamsters. 1969 Toxicol. Appl. Pharmacol. pmid:5787519
Gaeta GB et al. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. 1985 Toxicol. Appl. Pharmacol. pmid:2992120
Flaman AS et al. The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells. 2011 Toxicol. Appl. Pharmacol. pmid:21466820
Hayashi S et al. Characterization of multinuclear hepatocytes induced in rats by mitemcinal (GM-611), an erythromycin derivative. 2008 Toxicol Pathol pmid:18776165
Abdel-Hameid NA Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats. 2007 Toxicol In Vitro pmid:17267170
Tilmant K et al. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis. 2011 Toxicol In Vitro pmid:21515356
Peyre L et al. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. 2015 Toxicol In Vitro pmid:26239606
BARDIER A et al. [Results of infantile propiocine granulated for syrup in infections pathology in infants (Apropos of 71 cases)]. 1961 Toulouse Med pmid:13686911
BARDIER A et al. [CURRENT TREATMENT OF PLEURO-PULMONARY STAPHYLOCOCCAL INFECTIONS IN INFANTS (APROPOS OF 60 CASES)]. 1964 Toulouse Med pmid:14169371
DUBRA F [PATHOLOGY OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158172
DUBRA F [THE CURE OF PULMONARY TUBERCULOSIS CAUSED BY RESISTANT BACTERIA]. 1963 Sep-Dec Torax pmid:14158173
PALERMO FM [SECONDARY BACTERIAL RESISTANCE]. 1963 Sep-Dec Torax pmid:14159781
Giuliano MW and Miller SJ Site-Selective Reactions with Peptide-Based Catalysts. 2016 Top Curr Chem pmid:26307403
MUNOZBLAZQUEZ J [ANTIBIOTIC-CORTISONE TREATMENT OF GENITAL INFLAMMATION]. 1964 Tokoginecol Pract pmid:14108914
Hara T et al. Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy. 2006 Tokai J. Exp. Clin. Med. pmid:21302226
Partiarca PA et al. Outbreaks of pertussis in the United States: the Wisconsin experience. 1988 Tokai J. Exp. Clin. Med. pmid:3273611
Onodera T et al. Effect of fluid and antibiotic administration on experimental fecal peritonitis. 1968 Tohoku J. Exp. Med. pmid:5715596
Kanemitsu K et al. Efficacy of amikacin combinations for nocardiosis. 2003 Tohoku J. Exp. Med. pmid:14649737
Ramos CJ and Antonetti DA The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. 2017 Tissue Barriers pmid:28632993
van der Kuy A et al. [The erythromycin group]. 1974 Tijdschr Ziekenverpl pmid:4499128
van der Lely N et al. [A child with Chlamydia trachomatis pneumonia]. 1993 Tijdschr Kindergeneeskd pmid:8266317
Schurgers M et al. [A case of toxic hepatitis]. 1974 Tijdschr Gastroenterol pmid:4454054
Devriese L [Antibiotic sensitivity tests (author's transl)]. 1976 Tijdschr Diergeneeskd pmid:827819
Boswinkel M and Sloet van Oldruitenborgh-Oosterbaan MM [Diagnosis and therapy of Rhodococcus equi infection in the horse]. 2006 Tijdschr Diergeneeskd pmid:16989420
van der Toorn F and Lumeij JT [Streptococcus gallolyticus infections in racing pigeons, a literature review]. 2001 Tijdschr Diergeneeskd pmid:11227399
Bergan T [Erythromycin instead of tetracyclines to children]. 1978 Tidsskr. Nor. Laegeforen. pmid:684704
Gulbrandsen P and Fugelli P [Bad custom]. 1991 Tidsskr. Nor. Laegeforen. pmid:2000597
Nesbakken T et al. [Chlamydial inclusion conjunctivitis in the newborn. 5 cases]. 1982 Tidsskr. Nor. Laegeforen. pmid:7157283
Ose L [Encephalitis associated with mycoplasma pneumoniae infection in children]. 1975 Tidsskr. Nor. Laegeforen. pmid:1145545
Brauteset LV et al. [Invasive pneumoccal disease in children in Oslo 1998-2004]. 2008 Tidsskr. Nor. Laegeforen. pmid:18552897
Aas K [Treatment of infections in allergic patients]. 1974 Tidsskr. Nor. Laegeforen. pmid:4820866
Volden G [Syphilis]. 1980 Tidsskr. Nor. Laegeforen. pmid:6992342
Holst-Larsen L [Antibacterial agents. 4. Erythromycin]. 1972 Tidsskr. Nor. Laegeforen. pmid:4657026